Ohio Bioscience News

Click a news item to be directed to the full story. Send your news to bioohio@bioohio.com.

Found 7731 Results

OSU engineering professor earns $1.8 million NIH funding to develop new hearing loss treatment

Department of Computer Science and Engineering Professor DeLiang (Leon) Wang will lead a five-year $1.8 million research grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) to […]

February 13, 2013

Northeast Ohio Medical University, CEL-SCI produce new investigational breast cancer vaccine

In partnership with CEL-SCI Corporation, Northeast Ohio Medical University (NEOMED) has produced a new investigational breast cancer vaccine. In animal tests the J-HER vaccine has shown reduction of HER-2/neu expressing breast […]

February 8, 2013

Austen BioInnovation Institute leadership strengthened

Proven technology entrepreneur and executive Vince Kazmer has been named chief operating officer of the Austen BioInnovation Institute in Akron. During his career, Kazmer, a Hudson resident, founded four life […]

February 7, 2013

Spinal muscular atrophy research at Nationwide Children’s soars with foundation’s support

In 2012, Brian Kaspar and a team of Spinal Muscular Atrophy (SMA) experts at The Research Institute at Nationwide Children’s Hospital received a total of $650,000 in grants from Sophia’s […]

February 6, 2013

Cleveland Clinic’s Healthcare Innovation Alliance goes west

The Innovation Institute,  a brand new California collaborative launched by seven founding non-profit health systems, has become the newest member of  The Cleveland Clinic’s Healthcare Innovation Alliance. St. Joseph Health, a […]

February 6, 2013

Cold hard fact: Ohio universities leading organ cryopreservation research

An article about freezing human organs in the Feb. 1 issue of The Scientist was fascinating enough by itself. But it quickly got 4 degrees cooler with the signifant mentions […]

February 4, 2013

Hardy Diagnostics opens Springboro, Ohio production site

February 4, 2013 | Hardy Diagnostics

Arteriocyte receives FDA approval to begin cell therapy trial for battlefield wounds

Cleveland-based Arteriocyte has received FDA approval to initiate a Phase I clinical trial using its Magellan System technology in the treatment of thermal burn wounds. The company describes the Magellan […]

February 1, 2013